Gossamer Bio, Inc.
GOSSNASDAQHealthcare● Active
$0.17
$-0.01(-5.37%)
Market Cap$38865704
P/E Ratio—
52W High$3.87
52W Low$0.1625
Gossamer Bio, Inc. (GOSS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GOSS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $136.93M | $294.52M | $296.43M | $255.68M | $325.22M |
| Net Receivables | $12.53M | $5.34M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $167.64M | $309.89M | $306.52M | $261.88M | $331.78M |
| PP&E Net | $4.20M | $5.12M | $4.78M | $9.89M | $10.80M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $172.25M | $315.29M | $311.92M | $272.45M | $343.66M |
| Liabilities | |||||
| Short-Term Debt | $0.94M | $0.00M | $11.61M | $11.61M | $0.00M |
| Accounts Payable | $5.96M | $2.32M | $5.53M | $1.46M | $3.24M |
| Total Current Liabilities | $63.44M | $45.01M | $51.60M | $49.23M | $39.86M |
| Long-Term Debt | $198.51M | $197.52M | $197.41M | $207.70M | $179.12M |
| Total Liabilities | $295.01M | $285.80M | $249.15M | $260.37M | $222.19M |
| Stockholders Equity | |||||
| Retained Earnings | ($1438.94M) | ($1268.57M) | ($1212.04M) | ($1032.22M) | ($811.53M) |
| Total Stockholders Equity | ($122.76M) | $29.49M | $62.77M | $12.08M | $121.46M |
| Total Liab & Equity(computed) | $172.25M | $315.29M | $311.92M | $272.45M | $343.66M |
| Debt Summary | |||||
| Total Debt | $201.97M | $202.88M | $212.46M | $225.74M | $185.24M |
| Net Debt | $164.24M | $156.81M | $180.35M | $113.77M | $1.83M |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Gossamer Bio, Inc. data
About Gossamer Bio, Inc. (GOSS) Balance Sheet
Gossamer Bio, Inc. (GOSS) balance sheet shows total assets of $0.17B with cash of $0.14B. Total liabilities are $0.30B, total debt $0.20B, and stockholders equity ($0.12B).
Frequently asked questions
GOSS · 4 questionsGossamer Bio, Inc. has total debt of $0.20B with net debt of $0.16B.
GOSS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10